relative to insurance coverage for biomarker testing.

Sponsors & Cosponsors

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

1. Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC)

   5/1/2026House

2. Executive Session: 04/29/2026 10:00 am GP 229

   4/22/2026House

3. Subcommittee Work Session: 04/28/2026 10:00 am GP 229

   4/22/2026House

4. Subcommittee Work Session: 04/22/2026 10:00 am GP 229

   4/16/2026House

5. Subcommittee Work Session: 04/08/2026 10:00 am GP 229

   4/1/2026House

6. Public Hearing: 04/01/2026 11:00 am GP 229

   3/24/2026House

7. Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8

   3/16/2026House

8. Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6

   3/6/2026Senate

9. Committee Report: Ought to Pass, 03/12/2026; Vote 7-0; CC; SC 9

   3/5/2026Senate

10. Ought to Pass with Amendment #2026-0689s, MA, VV; Refer to Finance Rule 4-5; 02/19/2026; SJ 4

    2/18/2026Senate

11. Committee Amendment # 2026-0689s, AA, VV; 02/19/2026; SJ 4

    2/12/2026Senate

12. Committee Report: Ought to Pass with Amendment # 2026-0689s, 02/19/2026; Vote 5-0; CC; SC 6

    2/12/2026Senate

13. Hearing: 01/28/2026, Room 100, SH, 09:00 am; SC 3

    1/22/2026Senate

14. Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1

    11/25/2025Senate

Bill Text

• Introduced

  11/25/2025

  PDF